BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31267862)

  • 1. Impact of Antioxidant Natural Compounds on the Thyroid Gland and Implication of the Keap1/Nrf2 Signaling Pathway.
    Paunkov A; Chartoumpekis DV; Ziros PG; Chondrogianni N; Kensler TW; Sykiotis GP
    Curr Pharm Des; 2019; 25(16):1828-1846. PubMed ID: 31267862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare and common genetic variations in the Keap1/Nrf2 antioxidant response pathway impact thyroglobulin gene expression and circulating levels, respectively.
    Matana A; Ziros PG; Chartoumpekis DV; Renaud CO; Polašek O; Hayward C; Zemunik T; Sykiotis GP
    Biochem Pharmacol; 2020 Mar; 173():113605. PubMed ID: 31421134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of Keap1/Nrf2 signaling in the thyroid gland and perspectives for bench-to-bedside translation.
    Chartoumpekis DV; Ziros PG; Habeos IG; Sykiotis GP
    Free Radic Biol Med; 2022 Sep; 190():276-283. PubMed ID: 35988853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple regulations of Keap1/Nrf2 system by dietary phytochemicals.
    Qin S; Hou DX
    Mol Nutr Food Res; 2016 Aug; 60(8):1731-55. PubMed ID: 27523917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 is commonly activated in papillary thyroid carcinoma, and it controls antioxidant transcriptional responses and viability of cancer cells.
    Ziros PG; Manolakou SD; Habeos IG; Lilis I; Chartoumpekis DV; Koika V; Soares P; Kyriazopoulou VE; Scopa CD; Papachristou DJ; Sykiotis GP
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1422-7. PubMed ID: 23766517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keap1-Nrf2 signaling pathway: mechanisms of regulation and role in protection of cells against toxicity caused by xenobiotics and electrophiles.
    Turpaev KT
    Biochemistry (Mosc); 2013 Feb; 78(2):111-26. PubMed ID: 23581983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Nrf2-Keap1 signaling for chemoprevention of skin carcinogenesis with bioactive phytochemicals.
    Chun KS; Kundu J; Kundu JK; Surh YJ
    Toxicol Lett; 2014 Aug; 229(1):73-84. PubMed ID: 24875534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-κB and Nrf2-Keap1 signaling pathways.
    Gan FF; Ling H; Ang X; Reddy SA; Lee SS; Yang H; Tan SH; Hayes JD; Chui WK; Chew EH
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):852-62. PubMed ID: 23899529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Nrf2/Keap1 signaling pathway by bioactive natural agents: Possible therapeutic strategy to combat liver disease.
    Jayasuriya R; Dhamodharan U; Ali D; Ganesan K; Xu B; Ramkumar KM
    Phytomedicine; 2021 Nov; 92():153755. PubMed ID: 34583226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
    Chen CS; Tseng YT; Hsu YY; Lo YC
    Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related cataracts: Role of unfolded protein response, Ca
    Periyasamy P; Shinohara T
    Prog Retin Eye Res; 2017 Sep; 60():1-19. PubMed ID: 28864287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiology and Thyroid Cancer.
    Renaud CO; Ziros PG; Chartoumpekis DV; Bongiovanni M; Sykiotis GP
    Front Endocrinol (Lausanne); 2019; 10():510. PubMed ID: 31428048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Keap1/Nrf2 Signaling Pathway in the Thyroid-2020 Update.
    Thanas C; Ziros PG; Chartoumpekis DV; Renaud CO; Sykiotis GP
    Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33158045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones.
    de Freitas Silva M; Pruccoli L; Morroni F; Sita G; Seghetti F; Viegas C; Tarozzi A
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30037040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances of Natural Polyphenols Activators for Keap1-Nrf2 Signaling Pathway.
    Zhou Y; Jiang Z; Lu H; Xu Z; Tong R; Shi J; Jia G
    Chem Biodivers; 2019 Nov; 16(11):e1900400. PubMed ID: 31482617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 signaling pathway: Pivotal roles in inflammation.
    Ahmed SM; Luo L; Namani A; Wang XJ; Tang X
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):585-597. PubMed ID: 27825853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance.
    Jeddi F; Soozangar N; Sadeghi MR; Somi MH; Samadi N
    DNA Repair (Amst); 2017 Jun; 54():13-21. PubMed ID: 28415030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
    Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
    Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bis-Michael Acceptors as Novel Probes to Study the Keap1/Nrf2/ARE Pathway.
    Deny LJ; Traboulsi H; Cantin AM; Marsault É; Richter MV; Bélanger G
    J Med Chem; 2016 Oct; 59(20):9431-9442. PubMed ID: 27682717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular mechanism of Nrf2-Keap1 signaling pathway in the antioxidant defense response induced by BaP in the scallop Chlamys farreri.
    Wang H; Pan L; Xu R; Si L; Zhang X
    Fish Shellfish Immunol; 2019 Sep; 92():489-499. PubMed ID: 31220575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.